NIKI:NASDAQ, Niki BioSolutions Inc.

NIKI stock overview

Niki BioSolutions Inc. (NIKI:NASDAQ) closed at $1.76 on November 3, 2026, up 4.14% on the day. The stock trades 89.8% below its 52-week high of $17.20 and 5.4% above its 52-week low of $1.67. Over the past year, it lost 88.0%. Niki BioSolutions Inc. is part of the Health Care sector.

Key figures

Price: $1.76
Day change: +4.14%
Volume: 45,140
Average volume: 97,651
Market cap: 5M+
52-week range: $1.67 – $17.20
50-day average: $4.49
200-day average: $7.67

Price action over the past year

In 252 trading sessions since November 3, 2025, NIKI closed higher on 100 days (40%). Its best day was July 20, 2026 (+26.14%) and its worst was October 12, 2026 (-24.50%). The stock moved 10% or more in a single session 24 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

Nov 3, 2026: Hit a new 52-Week Low of $1.69 (New Highs/Lows scanner)
Oct 23, 2026: News catalyst: Agreement (News Catalysts scanner)
Oct 12, 2026: Dropped 24.5% in a single session (Dips & Crashes scanner)
Sep 4, 2026: Spiked to $9.68 on 4M+ shares (Spikes scanner)

NIKI news

About Niki BioSolutions Inc.

Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases.

Similar stocks

Find more stocks like NIKI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.